$AMGN Company News NYSE to expand number of companies

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$AMGN Company News

NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
Charting a Fed-induced market whipsaw 11:20 a.m. Oct. 9, 2014 - Michael Ashbaugh
Dow industrials venture to uncharted territory 9:53 a.m. Sept. 17, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 12:05 p.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:56 a.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:44 a.m. Aug. 19, 2014 - Michael Ashbaugh
Berkshire Hathaway tops $200,000; Cisco drops on results 12:19 p.m. Aug. 14, 2014 - Angela Johnson
Cisco volatile after hours in wake of earnings 5:03 p.m. Aug. 13, 2014 - Sue Chang
Amgen recalls syringes of anemia drug Aranesp 4:55 p.m. Aug. 13, 2014 - Russ Britt
CORRECT: Amgen shares fall after-hours on disappointing trial data 4:34 p.m. Aug. 13, 2014 - Tomi Kilgore
U.S. stocks rally; Dow snaps 4-session losing streak 4:14 p.m. Aug. 4, 2014 - Barbara Kollmeyer
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Angela Johnson
Amgen shares rally 2.7% to top S&P 500 9:30 a.m. Aug. 4, 2014 - Sue Chang
Amgen reports successful late-stage trial of cancer treatment 8:34 a.m. Aug. 4, 2014 - Joshua Jamerson
Amgen reports positive trial of multiple myeloma treatment 7:49 a.m. Aug. 4, 2014 - Ciara Linnane
Tesla Shares Weaken in After Hours 8:13 p.m. July 31, 2014 - MarketWatch
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - blogs.marketwatch.com
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - MarketWatch
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - blogs.marketwatch.com
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - blogs.marketwatch.com


Amgen Files Patent Infringement Suit 9:43 a.m. Today - The Wall Street Journal Interactive Edition
Amgen sues Sanofi and Regeneron 9:30 a.m. Today - Seeking Alpha
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 8:01 a.m. Today - benzinga.com
New Positive Clinical Data Supports Quest Towards Orphan Designations 6:45 a.m. Today - Seeking Alpha
3 Stocks Dragging In The Drugs Industry 1:22 p.m. Oct. 16, 2014 - TheStreet.com
Ad Comm meeting approaches for Novartis' psoriasis therapy candidate 11:46 a.m. Oct. 16, 2014 - Seeking Alpha
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog 1:59 p.m. Oct. 15, 2014 - Zacks.com
'Fast Money' Recap: Now May Be the Time to Buy Energy Stocks 5:00 a.m. Oct. 15, 2014 - TheStreet.com
6 Useful Categories of Stocks 12:02 p.m. Oct. 14, 2014 - GuruFocus.com
Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog 5:57 p.m. Oct. 13, 2014 - Zacks.com
Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog 5:55 p.m. Oct. 13, 2014 - Zacks.com
UBS Very Positive on Top Biotech Stocks Ahead of Earnings 7:58 a.m. Oct. 13, 2014 - 247WallSt.com
Most Top Industry Groups Fall Harder Than Market 5:35 p.m. Oct. 10, 2014 - Investors Business Daily
Today's Stocks Driving Success For The Drugs Industry 1:03 p.m. Oct. 10, 2014 - TheStreet.com
Amgen spin-out on deck for IPO 11:29 a.m. Oct. 10, 2014 - Seeking Alpha
Short Interest in Biotech Becomes Company Specific 9:24 a.m. Oct. 10, 2014 - 247WallSt.com
Put Amgen Back on Your Buy List 8:52 p.m. Oct. 9, 2014 - InvestorPlace.com
Amgen Up on Positive Phase III Data on Psoriasis Biosimilar - Analyst Blog 3:54 p.m. Oct. 9, 2014 - Zacks.com
UPDATE: Amgen's BiTE Received FDA Priority Review Designation 3:06 p.m. Oct. 9, 2014 - benzinga.com
Portfolio Changes For The Third Quarter 2014 9:14 a.m. Oct. 9, 2014 - Seeking Alpha


Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 9:00 a.m. Today - PR Newswire - PRF
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:40 p.m. Oct. 14, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia 4:05 p.m. Oct. 9, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis 9:15 a.m. Oct. 8, 2014 - PR Newswire - PRF
Global Biosimilar Market Outlook 2018 8:09 p.m. Oct. 1, 2014 - PR Newswire - PRF
The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol 7:01 p.m. Oct. 1, 2014 - PR Newswire - PRF
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Bococizumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 3:55 p.m. Sept. 29, 2014 - PR Newswire - PRF
Amgen to Host Summary Webcast of Kyprolis® (carfilzomib) for Injection Data Presented at The European Society for Medical Oncology (ESMO) 2014 Congress 5:02 p.m. Sept. 24, 2014 - PR Newswire - PRF
Q Therapeutics Expands Board of Directors With Appointment of Dr. Hunter Jackson as Independent Member 4:22 p.m. Sept. 23, 2014 - Marketwire
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien 9:05 a.m. Sept. 23, 2014 - PR Newswire - PRF
Amgen Submits Biologics License Application for Investigational BiTE® Immunotherapy Blinatumomab 9:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4:00 p.m. Sept. 15, 2014 - PR Newswire - PRF
Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire 8:50 a.m. Sept. 15, 2014 - PR Newswire - PRF
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9:00 p.m. Sept. 14, 2014 - PR Newswire - PRF
Reporting Bias in Clinical Trials: What's the current status? 10:30 a.m. Sept. 10, 2014 - PR Newswire - PRF
Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting 9:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Critical Alerts For Alcoa, Twitter, General Mills, SunEdison and Amgen Released By InvestorsObserver 9:31 a.m. Sept. 9, 2014 - PR Newswire - PRF
Zenith Epigenetics Strengthens its Management Team with Key Appointments 5:34 p.m. Sept. 8, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VEVOR's Labor Day Salute to Home DIY Warriors

Updated Category News Views 4

Celebrating the DIY Spirit When most folks think of Labor Day, they picture grilling and lounging. But there's a whole crew out there wielding hammers and paintbrushes, making the most of their long weekend. That's right, Labor Day isn't just rest for some; it's a roll-up-your-sleeves and get it done kind of holiday, and VEVOR is tipping its hat to those folks. Home...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 3

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Evolve & ELITEWHEELS: Shifting Gears in European Cycling

Updated Category News Views 3

Revving Up for the European Cycling Scene There's something about the open road and the whirr of wheels that gets blood pumping—maybe it's the competition, maybe it's the gear. Either way, this year's Italian Bike Festival is turning the Misano World Circuit into a battleground for cycling's elite, with evolve and ELITEWHEELS charging at the forefront. They're not just...

Continue Reading
Unlocking Insights: South Chicagoland Home Inspections

Updated Category News Views 1

Sizing Up South Chicagoland Homes: What Really Gets Inspected In the world of real estate transactions, home inspections stand like grizzled veterans, proudly scrutinizing every nook and cranny before the ink dries on a property deed. Here in South Chicagoland, where the echoes of every frigid winter and sweltering summer linger, the process becomes a lifeline for buyers...

Continue Reading
UGREEN's AI Hub: Privacy-First Tech for Smart Homes

Updated Category News Views 2

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...

Continue Reading
Nocpix's Evolution: New Thermal Riflescope Unveiled

Updated Category News Views 2

Raising the Thermal Image Bar When Nocpix, known for cutting-edge electro-optical tech, teases a new thermal riflescope, it's time for hunters to perk up. This ain't just another gadget. We're talking about equipment that elevates precision and brings an edge to the field. Scheduled for hunters who mean business, this next-gen scope is destined to redefine what it means...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 1

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 1

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 0

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Updated Category News Views 1

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Used Forklift Inventory on the Rise: Market Impact and Trends

Updated Category News Views 189

Rising Levels of Used Forklift Inventory The used forklift market is currently experiencing significant growth, marked by an impressive climb in inventory levels. Notably, a recent report shows a remarkable 29.07% increase year-over-year as of October. This surge is not limited to standard forklifts; it extends to aerial lifts and telehandlers as well, creating a robust...

Continue Reading
Rush Enterprises Showcases Resilience with Strong Financials

Updated Category News Views 84

Overview of Financial Performance Rush Enterprises, Inc. (NASDAQ: RUSHA) has released its financial results for the year 2024, highlighting a robust revenue generation despite significant industry challenges. With annual revenues reaching $7.8 billion and a net income of $304.2 million, the company exemplifies strength amid market fluctuations. This translates to earnings...

Continue Reading
Foundry JV Holdco LLC Initiates Consent Solicitation for Notes

Updated Category News Views 649

Foundry JV Holdco LLC Begins Consent Solicitation Process Foundry JV Holdco LLC, a limited liability company based in Delaware, has announced its initiation of a consent solicitation concerning its 5.900% Senior Secured Notes due 2030, among others. This solicitation is aimed at holders of various series of outstanding Senior Secured Notes, which include rates ranging...

Continue Reading
PMB and Sharp Rees-Stealy Launch State-of-the-Art Medical Facility

Updated Category News Views 100

Enhancing Healthcare Access in the Community PMB, a well-known healthcare real estate developer, has partnered with Sharp Rees-Stealy to bring a new medical outpatient building to the community. This impressive 75,000 square-foot facility spans three stories and showcases a commitment to advancing healthcare services in the region. Built specifically for the residents of...

Continue Reading
Neinor Homes Announces Significant Shareholder Distributions Plan

Updated Category News Views 117

Neinor Homes Plans Shareholder Distributions Recently, Neinor Homes has unveiled an exciting plan to distribute €125 million to its shareholders, reaffirming its dedication to enhancing shareholder value. This substantial distribution will take place in the early months of 2025, with each share garnering a payout of €1.66, translating to an impressive yield of 11%....

Continue Reading